Origin of 1004 Venture Partners
We are investors, biotech researchers, and serial entrepreneurs—but first, we are sons and daughters. Having witnessed how modern healthcare fails our aging loved ones, we founded 1004 Venture Partners to radically improve the final decades of life. The emotional and economic burden on seniors, families, and caregivers is unsustainable, but the solution lies in unprecedented technological convergence. By backing breakthrough startups leveraging AI for advanced therapeutics, intelligent medical devices, and aging-in-place infrastructure, we transform senior care from a systemic crisis into a dignified experience. We sit at the intersection of profound human need and a rapidly expanding global longevity economy. Our unique blending of scientific rigor and operational experience equips us to capture this massive market momentum, delivering top-tier financial returns alongside measurable societal impact.
Our thesis is driven by a leadership team uniquely equipped to navigate the complex intersection of healthcare, artificial intelligence, and longevity. 1004 Venture Partners leverages over 35 years of collective expertise in the biotech, life sciences, and medtech ecosystems.
Scientific Authority: Built upon rigorous institutional foundations, including extensive research and leadership experience at world-class universities and startups.
Operational Grit: Driven by seasoned venture partners and tech founders with direct operational oversight across multiple life science startups, steering them from inception to successful IPOs and private acquisitions.
Investment Precision: Guided by specialized investment professionals with a proven track record of early-stage due diligence, capital deployment, and robust portfolio management.
Proprietary Deal Flow: Institutional roots and industry networks that provide 1004 Venture Partners early, unparalleled access to elite, heavily guarded healthtech and age-tech pipelines.
Active Value Creation: Hands-on operational mastery that bridges the gap from laboratory discovery, through complex FDA clinical tracks, to scalable commercial exit strategies.
This powerful combination of scientific fluency and hands-on commercial experience ensures we do not just spot high-potential startups—we actively accelerate them.
1004VP is an official VC Partner of
Meet the Team
-
Soyoung Park, MBA
General Partner
-
Benny Larson, PhD
Principal
-
Min Bang, PharmD
Analyst Intern